Medicines for all - what is hindering progress?

Saturday 3 October 2015
14:30-17:30
C4, 3 hours

Organised by the FIP Industrial Pharmacy Section and the FIP Military & Emergency Pharmacy Section

Introduction

"Medicines for All" has been a WHO and FIP mantra for over two decades. While an eminently laudable goal, it has not been achieved. What is hindering progress? This session will explore potential reasons why essential medicines are not available to the entire population of all countries, developed and developing, and examines potential solutions.

Learning objectives

Knowledge-based session

At the conclusion of this session, participants will be able to:

  1. Identify the political reasons why medicines are not available for all.
  2. Explain the pragmatic logistic reasons why medicines are not available for all.
  3. Outline the financial reasons why medicines are not available for all.
  4. Challenge the pharmaceutical industry's perspective of why medicines are not available for all.

Chairs: Gabrielle Wiederkehr (ACCESS Regulatory Consulting, Switzerland) and Michael Anisfeld (Globepharm Consulting, USA)

Programme

14:30 1) Introduction

14:35 2) The practical difficulties of delivering medicines during natural disasters
Trudi Hilton (International Health Partners, UK)

15:10 3) The practical difficulties of delivering medicines where infra-structure does not exist, period!
Emmanuel Nfor (Systems to Improve Access to Pharmaceuticals and Services - SIAPS, USA)

15:45 Break

16:05 4) Good distribution practices and problems with the last mile
Michael Anisfeld (Globepharm Consulting, Inc., USA)

16:40 5) Does the international pharmaceutical industry have a responsibility to make medicines available for all? And if so, what is the responsibility?
Ulf Janzon (FIP IPS, Sweden)

17:15 6) Discussion between speakers and audience about the issues and problems highlighted by speakers and potential solutions